drugset / Trial / NCT00598234

Perioperative Pain Control With Celecoxib (Celebrex) in Total Knee Arthroplasty

NCT00598234

Phase 4 Completed 120 enrolled National Taiwan University Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

We propose that administration perioperative celecoxib is effective to control postoperative VAS pain scores, improve rehabilitation results, and decrease narcotics usage in total knee replacement patients.

Timeline

Start
2006-09
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Celecoxib Other / unclassified 200 mg Oral

Indications